Menu

Lumos Pharma, Inc. LUMO

Full chart Compare
Set alert

Price alert · LUMO

All alert types
4.34 +4.34

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $2.55MIncome Tax Benefit → Expenses: $29.00KExpenses → Selling, General & Admin: $16.57MExpenses → Research & Development: $22.10MGross Profit → Expenses: $2.05MRevenue → Gross Profit: $2.05MNet Loss → Expenses: $34.03MOther Income$2.55MIncome Tax Benefit$29.00KGross Profit$2.05MNet Loss$34.03MExpenses$38.66MSelling, General & Admin$16.57MResearch & Development$22.10MRevenue$2.05M

Latest period ending Dec 31, 2023 · select a line to chart its full history

Annual income statement

LUMO annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
2.05M1.52M230.00K168.00K0
2.05M1.52M230.00K168.00K0
2.05M1.52M230.00K168.00K0
38.66M33.56M31.58M26.47M9.82M
22.10M17.86M16.25M9.21M5.67M
16.57M15.71M15.33M17.27M4.15M
-36.61M-32.04M-31.35M-26.30M-9.82M
-29.00K-13.00K-636.00K-13.97M0
-34.03M-31.06M-30.43M-5.66M-9.71M
-34.03M-31.06M-30.43M-6.31M-12.74M
-34.03M-31.06M-30.43M-6.31M-12.74M
-34.03M-31.06M-30.43M-5.66M-9.71M
-4.18-3.71-3.65-0.93-9.79
-4.18-3.71-3.65-0.93-9.79
-4.18-3.71-3.65-0.93-9.79
-34.06M-31.07M-31.07M-19.64M-9.71M
-34.06M-31.07M-31.07M-19.64M-9.71M
8.15M8.37M8.33M6.78M1.30M
8.15M8.37M8.33M6.78M1.30M